Journals / Turkish Journal of Endocrinology and Metabolism / 2020 / Cilt: 24 - Sayı: 1

Granülomatöz Polianjitisin Nadir Bir Tutulumu: Diabetes İnsipidus Olgusu

Granulomatosis Polyangiitis Presented with Diabetes Insipidus

Pages
96–100
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Biz bu olgumuzda, diabetes inspidus ile prezante olan bir GPA vakası sunduk.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Granülomatöz polianjitis (GPA), küçük ve orta ölçekli damarların sistemik bir vaskülitidir.
📊
Key Findings & Data:Başlıca üst ve alt solunum yollarını etkiler.
💡
Conclusion & Impact:Biz bu olgumuzda, diabetes inspidus ile prezante olan bir GPA vakası sunduk.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Granülomatöz polianjitis (GPA), küçük ve orta ölçekli damarların sistemik bir vaskülitidir. Patogenezi tam olarak anlaşılamamıştır. Başlıca üst ve alt solunum yollarını etkiler. Ancak, sinir sistemi tutulumu da söz konusudur. En sık olarak, periferal nöropatilere veya kraniyal sinir felcine yol açan nekrotizan vaskülit olarak kendini gösterir. Santral sinir sistemi (SSS) bozukluğu daha az sıklıkta görülür. SSS tutulumu 3 şekilde olabilir: Vaskülitik tutulum, komşu anatomik alanlardan granülom yayılımı ve beyin dokusunda yeni granülom oluşumu. Biz bu olgumuzda, diabetes inspidus ile prezante olan bir GPA vakası sunduk.

Özet

The pathogenesis of granulomatosis polyangiitis (GPA), systemic vasculitis of small and medium-size vessels, is not completely understood. GPA mainly affects the upper and lower respiratory tract. However, it may involve the central nervous system (CNS) as well. The most common manifestation of CNS involvement is necrotizing vasculitis, leading to peripheral neuropathies or cranial nerve palsy. CNS disorder is less common. CNS involvement in GPA can manifest itself in three ways: Vasculitic involvement, granuloma spread from adjacent anatomical areas, and new granuloma formation in brain tissue. We present a case of GPA presented with diabetes insipidus.

🔖

Cite This Article

KOCA, E., TARHAN, E. F., ELİBOL, F. D., ÇINAR, N. (2020). Granülomatöz Polianjitisin Nadir Bir Tutulumu: Diabetes İnsipidus Olgusu. Turkish Journal of Endocrinology and Metabolism, Cilt: 24 - Sayı: 1, 96–100. https://ajindex.com/articles/370692

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. De Parisot A, Puechal X, Langrand C, Raverot G, Gil H, Perard L, Le Guenno G, Berthier S, Tschirret O, Eschard JP, Vinzio S, Guillevin L, Sève P
  2. French Vasculitis Study Group. Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature. Medicine (Baltimore). 2015
  3. e748. [Crossref] [PubMed] [PMC] 2. Garrahy A, Moran C, Thompson CJ. Diagnosis and management of central diabetes insipidus in adults. Clin Endocrinol (Oxf). 2019
  4. [Crossref] [PubMed] 3. Kapoor E, Cartin-Ceba R, Specks U, Leavitt J, Erickson B, Erickson D. Pituitary dysfunction in granulomatosis with polyangiitis: the Mayo Clinic Experience. J Clin Endocrinol Metab. 2014
  5. [Crossref] [PubMed] 4. Ahlstrom CG, Liedholm K, Truedsson E. Respiratorenal type of polyarteritisnodosa. Acta Med Scand. 1953
  6. [Crossref] [PubMed] 5. Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ. Pituitary involvement by Wegener’s granulomatosis: a report of two cases. AJNR Am J Neuroradiol. 1999
  7. [PubMed] 6. Garovic VD, Clarke BL, Chilson TS, Specks U. Diabetes insipidus and anterior pituitary insuciency as presenting fe tures of Wegener’s granulomatosis. Am J Kidney Dis. 2001
  8. E5. [Crossref] [PubMed] 7. Miesen WM, Janssens EN, van Bommel EF. Diabetes insipidus as the presenting symptom of Wegener’s granulomatosis. Nephrol Dial Transplant. 1999
  9. [Crossref] [PubMed] 8. Tappouni R, Burns A. Pituitary involvement in Wegener’s granulomatosis. Nephrol Dial Transplant. 2000
  10. [Crossref] [PubMed] 9. Haynes BF, Fauci AS. Diabetes insipidus associated with Wegener’s granulomatosis successfully treated with cyclophosphamide. N Engl J Med. 1978
  11. [Crossref] [PubMed] 10.Rosete A, Cabral AR, Kraus A, Alarcón-Segovia D. Diabetes insipidus secondary to Wegener’s granulomatosis: report and review of the literature. J Rheumatol. 1991
  12. [PubMed] 11.Carpinteri R, Patelli I, Casanueva FF, Giustina A. Pituitary tumours: in ammatory and granulomatous expansive lesions of the pituitary. Best Pract Res Clin Endocrinol Metab. 2009
  13. [Crossref] [PubMed] 12. Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener’s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993
  14. [Crossref] [PubMed] 13. Yong TY, Li JY, Amato L, Mahadevan K, Phillips PJ, Coates PS, Coates PT. Pituitary involvement in Wegener’s granulomatosi